FDA Advisers Back Amgen (AMGN)'s Anemia Drugs for Kidney Patients  
10/19/2010 7:32:58 AM

Boston Globe -- WASHINGTON —Patients with failing kidneys should continue taking a group of widely used anemia drugs, despite a study showing they can increase the risk of stroke, advisers to the Food and Drug Administration recommended yesterday in a 15-to-1 vote.